Ischemia-modified albumin in acute stroke

Halim Abboud1, Julien Labreuche, Elena Meseguer

  • 1Department of Neurology and Stroke Center, Bichat University Hospital, Denis Diderot University and Medical School, Paris, France.

Summary

Ischemia-modified albumin (IMA) shows potential as a biomarker for early acute stroke identification. IMA levels increased in brain infarction patients but remained stable in brain hemorrhage patients within 24 hours.